CytoTools AG announced that it has issued 1,109,498 common shares at an issue price of 3.95 per share for gross proceeds of 4,382,517.1 on May 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.488 EUR | 0.00% | +4.72% | +9.42% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 2.69M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- CytoTools AG announced that it has received €4.382517 million in funding